Risk of Cardiovascular Events in Patients With Diabetes Mellitus on β-Blockers
نویسندگان
چکیده
Although the use of β-blockers may help in achieving maximum effects of intensive glycemic control because of a decrease in the adverse effects after severe hypoglycemia, they pose a potential risk for the occurrence of severe hypoglycemia. This study aimed to evaluate whether the use of β-blockers is effective in patients with diabetes mellitus and whether its use is associated with the occurrence of severe hypoglycemia. Using the ACCORD trial (Action to Control Cardiovascular Risk in Diabetes) data, we performed Cox proportional hazards analyses with a propensity score adjustment. The primary outcome was the first occurrence of a cardiovascular event during the study period, which included nonfatal myocardial infarction, unstable angina, nonfatal stroke, and cardiovascular death. The mean follow-up periods (±SD) were 4.6±1.6 years in patients on β-blockers (n=2527) and 4.7±1.6 years in those not on β-blockers (n=2527). The cardiovascular event rate was significantly higher in patients on β-blockers than in those not on β-blockers (hazard ratio, 1.46; 95% confidence interval, 1.24-1.72; P<0.001). In patients with coronary heart disease or heart failure, the cumulative event rate for cardiovascular events was also significantly higher in those on β-blockers than in those not on β-blockers (hazard ratio, 1.27; 95% confidence interval, 1.02-1.60; P=0.03). The incidence of severe hypoglycemia was significantly higher in patients on β-blockers than in those not on β-blockers (hazard ratio, 1.30; 95% confidence interval, 1.03-1.64; P=0.02). In conclusion, the use of β-blockers in patients with diabetes mellitus was associated with an increased risk for cardiovascular events.
منابع مشابه
Effects of β‐blockers on all‐cause mortality in patients with type 2 diabetes and coronary heart disease
AIMS To assess whether the use of beta-blockers influences mortality and the incidence of major cardiovascular events in patients with diabetes and coronary heart disease (CHD). MATERIALS AND METHODS Using data from the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial, we performed Cox proportional hazards analysis to assess the effects of β-blockers on all-cause mortality ...
متن کاملمقایسهء اثرات روغن ماهی و روغن ذرت برسطح لیپیدهای سرم بیماران دیابتی نوع2 مراجعه کننده به کلینیک دیابت زاهدان، سال 83-82
Background: The prevalence of Diabetes mellitus as the most common metabolic disorder of human is progressively increasing. Dyslipidemia is common among diabetic patients characterized by elevated plasma TG, LDL-C and reduced HDL-C levels which increase risk of cardiovascular events. Fish oil supplement which contains omega-3 has been proposed to correct the atherogenic lipid profile associated...
متن کاملDiabetic Patients’ Experience of Coping with Diabetes Mellitus: A Grounded Theory Study
Introduction: Diabetes mellitus (DM) is a chronic disease with high prevalence in the world and Iran. Uncontrolled DM puts financial pressure on health system and society. It also affects patients physically and mentally, and changes their social relationship with others. In spite of advances in DM control, there is only a little information regarding patients’ experience of living with DM and ...
متن کاملTrends in the Prevalence of Diabetes Mellitus in Patients with Myocardial Infarction in the South of Iran: 2008 to 2014
Background: Diabetes mellitus is a strong risk factor for cardiovascular disease, including acute myocardial infarction (AMI). Management of risk factors and the other prevention services in recent years lead to a significant decrease in AMI incidence. However, to examine the success of those strategies to control diabetes, this study aimed to identify the trends in prevalence of diabetes melli...
متن کامل